These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 39294263)
41. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Meulmeester E; Kunze M; Hsiao HH; Urlaub H; Melchior F Mol Cell; 2008 Jun; 30(5):610-9. PubMed ID: 18538659 [TBL] [Abstract][Full Text] [Related]
42. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases. Wang W; Matunis MJ Cells; 2023 Dec; 13(1):. PubMed ID: 38201212 [TBL] [Abstract][Full Text] [Related]
43. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264 [TBL] [Abstract][Full Text] [Related]
44. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. Gocke CB; Yu H; Kang J J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718 [TBL] [Abstract][Full Text] [Related]
48. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions. Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793 [TBL] [Abstract][Full Text] [Related]
49. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659 [TBL] [Abstract][Full Text] [Related]
50. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins. Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256 [TBL] [Abstract][Full Text] [Related]
51. Functional characterization of the SIZ/PIAS-type SUMO E3 ligases, OsSIZ1 and OsSIZ2 in rice. Park HC; Kim H; Koo SC; Park HJ; Cheong MS; Hong H; Baek D; Chung WS; Kim DH; Bressan RA; Lee SY; Bohnert HJ; Yun DJ Plant Cell Environ; 2010 Nov; 33(11):1923-34. PubMed ID: 20561251 [TBL] [Abstract][Full Text] [Related]
53. In vitro and in cellulae methods for determining the target protein SUMOylation. T K S; Panda AK; Kawadkar J; Bindra D; Joshi PA; Joshi G; Singh HV; Mishra RK Methods Enzymol; 2022; 675():397-424. PubMed ID: 36220279 [TBL] [Abstract][Full Text] [Related]
54. SUMO-conjugating and SUMO-deconjugating enzymes from Arabidopsis. Colby T; Matthäi A; Boeckelmann A; Stuible HP Plant Physiol; 2006 Sep; 142(1):318-32. PubMed ID: 16920872 [TBL] [Abstract][Full Text] [Related]
56. Small ubiquitin-like modifier conjugating enzyme with active site mutation acts as dominant negative inhibitor of SUMO conjugation in arabidopsis(F). Tomanov K; Hardtke C; Budhiraja R; Hermkes R; Coupland G; Bachmair A J Integr Plant Biol; 2013 Jan; 55(1):75-82. PubMed ID: 23206124 [TBL] [Abstract][Full Text] [Related]
57. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system. Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264 [TBL] [Abstract][Full Text] [Related]
58. In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. Blomster HA; Imanishi SY; Siimes J; Kastu J; Morrice NA; Eriksson JE; Sistonen L J Biol Chem; 2010 Jun; 285(25):19324-9. PubMed ID: 20388717 [TBL] [Abstract][Full Text] [Related]
59. The SUMOylation of Human Cytomegalovirus Capsid Assembly Protein Precursor (UL80.5) Affects Its Interaction with Major Capsid Protein (UL86) and Viral Replication. Zhang Z; Xia S; Wang Z; Yin N; Chen J; Shao L Viruses; 2023 Apr; 15(4):. PubMed ID: 37112911 [TBL] [Abstract][Full Text] [Related]
60. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival. Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]